
    
      All subjects will be clinically assessed using standard measures of clinical care. Cognitive
      function will be assessed by the Montreal Cognitive Assessment (MoCA). Disease severity will
      be assessed by the Clinical Dementia Rating Scale (CDR). Social function will be assessed by
      the Functional Activities Questionnaire (FAQ). Based on clinical assessment, subjects will be
      classified into one of the following groups.

        1. Normal (Spouse or Caregiver)

        2. Mild cognitive impairment

        3. Alzheimer's disease A. Mild B. Moderate C. Severe

      The investigators plan to enroll 60 subjects in each group from 1 and 2; 40 subjects in each
      of the groups 3A and 3B and 20 subjects in group 3C.
    
  